Essential Partners’s Tenaya Therapeutics TNYA Stock Holding History

Essential Partners’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-480	Closed	-$778	–	2914
2025 Q3	$778	Sell	480 -4,717	-91%	-$4.75K	﹤0.01%	2095
2025 Q2	$3.18K	Buy	+5,197	New	+$2.65K	﹤0.01%	1182

Other funds holding TNYA

Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Empery Asset Management New York $86.5M AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BGM

Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Essential Partners's TNYA Position: Q4 2025 in Review

Essential Partners sold out of Tenaya Therapeutics (TNYA) in Q4 2025, closing a stake of 480 shares — an estimated $778 sold.

Essential Partners first reported a position in TNYA in Q2 2025 and held it in 2 quarters. The position peaked at $3.18K in Q2 2025. 98 funds tracked by Wall St. Rank hold TNYA as of Q4 2025.

Essential Partners reported no remaining Tenaya Therapeutics position as of Q4 2025 after selling out during the quarter.
Essential Partners sold 480 Tenaya Therapeutics shares in Q4 2025, an estimated $778.
Essential Partners first reported a position in Tenaya Therapeutics in Q2 2025 and held it in 2 quarters.
Essential Partners's Tenaya Therapeutics position peaked at $3.18K in Q2 2025.
98 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q4 2025.

Based on Essential Partners's 13F filing for Q4 2025, filed 21 May 2026.